Flexion Therapeutics, Inc.
FLXN
FLXN was delisted on the 18th of November, 2021.
44 hedge funds and large institutions have $238M invested in Flexion Therapeutics, Inc. in 2014 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 24 increasing their positions, 6 reducing their positions, and 3 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 6
233% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 3
116% more capital invested
Capital invested by funds: $110M → $238M (+$128M)
16% more funds holding
Funds holding: 38 → 44 (+6)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$28.5M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$23.6M |
| 3 |
Jennison Associates
New York
|
+$16.1M |
| 4 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$9.06M |
| 5 |
KCM
Kingdon Capital Management
New York
|
+$8.41M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
-$2.73M |
| 2 |
VAM
Visium Asset Management
New York
|
-$2.65M |
| 3 |
GTC
Ghost Tree Capital
New York
|
-$228K |
| 4 |
NFG
Next Financial Group
Houston,
Texas
|
-$35K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$14.3K |
FLXN Hedge Fund Activity: Q4 2014 in Review
44 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Flexion Therapeutics, Inc. (FLXN) for Q4 2014, worth a combined $238M — up 116% from $110M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new FLXN positions and 3 closed out — a net gain of 7 holders — while 24 added to existing stakes and 6 trimmed.
The largest buyer was Gilder Gagnon Howe & Co, opening a new position worth an estimated $28.5M. The largest seller was Redmile Group, cutting an estimated $2.73M.
- 44 institutional investors held Flexion Therapeutics, Inc. (FLXN) as of Q4 2014, up from 38 in Q3 2014.
- Funds reported $238M of Flexion Therapeutics, Inc. stock for Q4 2014, up 116% quarter-over-quarter.
- 10 funds opened new Flexion Therapeutics, Inc. positions in Q4 2014 and 3 closed out, a net change of +7 holders.
- The largest Flexion Therapeutics, Inc. buyer in Q4 2014 was Gilder Gagnon Howe & Co, an estimated $28.5M added.
- The largest Flexion Therapeutics, Inc. seller in Q4 2014 was Redmile Group, an estimated $2.73M sold.
Based on aggregated 13F filings for Q4 2014.